A Pipeline that Builds on CologuardĀ®

Our Product Pipeline

Our approach to research and development and the experience of our R&D staff give us a unique advantage as we develop new cancer screening tests and pursue our vision: to help win the war on cancer through early detection.

Exact Sciences Chief Science Officer Graham Lidgard discussed these unique advantages at our inaugural Investor & Analyst Day in 2015.